Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness

NCT04272255 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Motion Sickness

Interventions

DRUG: scopolamine HBr
DRUG: Transdermal Scopolamine

Sponsor

Repurposed Therapeutics, Inc.